fHepaSense was a joint venture between Isis and Elan to develop a Hepatitis C virus antisense drug.

History:

Elan's participatiion was terminated in November 2002.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Southern California

Research Focus:
Disease Therapeutics-Clinical early (I, II)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: